These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 38431035)

  • 1. Glutamine inhibition combined with CD47 blockade enhances radiotherapy-induced ferroptosis in head and neck squamous cell carcinoma.
    Song A; Wu L; Zhang BX; Yang QC; Liu YT; Li H; Mao L; Xiong D; Yu HJ; Sun ZJ
    Cancer Lett; 2024 Apr; 588():216727. PubMed ID: 38431035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ASCT2 (SLC1A5)-dependent glutamine uptake is involved in the progression of head and neck squamous cell carcinoma.
    Zhang Z; Liu R; Shuai Y; Huang Y; Jin R; Wang X; Luo J
    Br J Cancer; 2020 Jan; 122(1):82-93. PubMed ID: 31819178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting of FSP1 regulates iron homeostasis in drug-tolerant persister head and neck cancer cells via lipid-metabolism-driven ferroptosis.
    Wu YC; Huang CS; Hsieh MS; Huang CM; Setiawan SA; Yeh CT; Kuo KT; Liu SC
    Aging (Albany NY); 2024 Jan; 16(1):627-647. PubMed ID: 38206305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A genome-wide CRISPR screen reveals that antagonism of glutamine metabolism sensitizes head and neck squamous cell carcinoma to ferroptotic cell death.
    Allevato MM; Trinh S; Koshizuka K; Nachmanson D; Nguyen TC; Yokoyama Y; Wu X; Andres A; Wang Z; Watrous J; Molinolo AA; Mali P; Harismendy O; Jain M; Wild R; Gutkind JS
    Cancer Lett; 2024 Aug; 598():217089. PubMed ID: 38964731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD47-SIRPĪ± Blockade Sensitizes Head and Neck Squamous Cell Carcinoma to Cetuximab by Enhancing Macrophage Adhesion to Cancer Cells.
    Li B; Hao Y; He H; Fan Y; Ren B; Peng X; Zhou X; Cheng L
    Cancer Res; 2024 Oct; 84(19):3189-3206. PubMed ID: 38959336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ASCT2 (SLC1A5) is an EGFR-associated protein that can be co-targeted by cetuximab to sensitize cancer cells to ROS-induced apoptosis.
    Lu H; Li X; Lu Y; Qiu S; Fan Z
    Cancer Lett; 2016 Oct; 381(1):23-30. PubMed ID: 27450723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of ferroptosis in radiotherapy and combination therapy for head and neck squamous cell carcinoma (Review).
    Feng Y; Li X; Yang B; Li M; Du Y; Wang J; Liu S; Gong L; Li L; Gao L
    Oncol Rep; 2024 Jun; 51(6):. PubMed ID: 38639185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TP63 transcriptionally regulates SLC7A5 to suppress ferroptosis in head and neck squamous cell carcinoma.
    Chen Z; Cai H; Ye W; Wu J; Liu J; Xie Y; Feng S; Jin Y; Lv Y; Ye H; Cai C; Cai G
    Front Immunol; 2024; 15():1445472. PubMed ID: 39234254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DRP1 inhibition-mediated mitochondrial elongation abolishes cancer stemness, enhances glutaminolysis, and drives ferroptosis in oral squamous cell carcinoma.
    Wang Z; Tang S; Cai L; Wang Q; Pan D; Dong Y; Zhou H; Li J; Ji N; Zeng X; Zhou Y; Shen YQ; Chen Q
    Br J Cancer; 2024 May; 130(11):1744-1757. PubMed ID: 38582810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MitoTam induces ferroptosis and increases radiosensitivity in head and neck cancer cells.
    Reinema FV; Hudson N; Adema GJ; Peeters WJM; Neuzil J; Stursa J; Werner L; Sweep FCGJ; Bussink J; Span PN
    Radiother Oncol; 2024 Nov; 200():110503. PubMed ID: 39186982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glutaminolysis-related genes determine sensitivity to xCT-targeted therapy in head and neck squamous cell carcinoma.
    Okazaki S; Umene K; Yamasaki J; Suina K; Otsuki Y; Yoshikawa M; Minami Y; Masuko T; Kawaguchi S; Nakayama H; Banno K; Aoki D; Saya H; Nagano O
    Cancer Sci; 2019 Nov; 110(11):3453-3463. PubMed ID: 31444923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic targeting of thioredoxin reductase 1 causes ferroptosis while potentiating anti-PD-1 efficacy in head and neck cancer.
    Hsieh MS; Ling HH; Setiawan SA; Hardianti MS; Fong IH; Yeh CT; Chen JH
    Chem Biol Interact; 2024 May; 395():111004. PubMed ID: 38636790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glutamine Transporter SLC1A5 Regulates Ionizing Radiation-Derived Oxidative Damage and Ferroptosis.
    Yuan Z; Liu T; Huo X; Wang H; Wang J; Xue L
    Oxid Med Cell Longev; 2022; 2022():3403009. PubMed ID: 36262284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiation-induced exosomes promote oral squamous cell carcinoma progression via enhancing SLC1A5-glutamine metabolism.
    Yang R; Zhang S; Wang L; Chen Y; Chen X; Xia J; Ren X; Cheng B; Chen X
    J Oral Pathol Med; 2024 Aug; 53(7):458-467. PubMed ID: 38802300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The potential therapeutic targets of glutamine metabolism in head and neck squamous cell carcinoma.
    Guo S; Wang X; Wang Y; Bai J; Liu Y; Shao Z
    Biomed Pharmacother; 2024 Jul; 176():116906. PubMed ID: 38876051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-137 regulates ferroptosis by targeting glutamine transporter SLC1A5 in melanoma.
    Luo M; Wu L; Zhang K; Wang H; Zhang T; Gutierrez L; O'Connell D; Zhang P; Li Y; Gao T; Ren W; Yang Y
    Cell Death Differ; 2018 Aug; 25(8):1457-1472. PubMed ID: 29348676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Glutamine-Rich Carrier Efficiently Delivers Anti-CD47 siRNA Driven by a "Glutamine Trap" To Inhibit Lung Cancer Cell Growth.
    Wu J; Li Z; Yang Z; Guo L; Zhang Y; Deng H; Wang C; Feng M
    Mol Pharm; 2018 Aug; 15(8):3032-3045. PubMed ID: 29939755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glutamine addiction activates polyglutamine-based nanocarriers delivering therapeutic siRNAs to orthotopic lung tumor mediated by glutamine transporter SLC1A5.
    Wang C; Wu J; Wang Z; Yang Z; Li Z; Deng H; Li L; Peng X; Feng M
    Biomaterials; 2018 Nov; 183():77-92. PubMed ID: 30149232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting ferroptosis for improved radiotherapy outcomes in HPV-negative head and neck squamous cell carcinoma.
    Noh JK; Lee MK; Lee Y; Bae M; Min S; Kong M; Lee JW; Kim SI; Lee YC; Ko SG; Woo SR; Eun YG
    Mol Oncol; 2024 Sep; ():. PubMed ID: 39297393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blocking EREG/GPX4 Sensitizes Head and Neck Cancer to Cetuximab through Ferroptosis Induction.
    Jehl A; Conrad O; Burgy M; Foppolo S; Vauchelles R; Ronzani C; Etienne-Selloum N; Chenard MP; Danic A; Dourlhes T; Thibault C; Schultz P; Dontenwill M; Martin S
    Cells; 2023 Feb; 12(5):. PubMed ID: 36899869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.